REDUCED NATURAL KILLER LYMPHOMANERI A; BRUGIATELLI M; TOPUZ UO et al.1981; BOLL. IST. SIEROTER. MILAN.; ISSN 0021-2547; ITA; DA. 1981; VOL. 60; NO 5; PP. 394-407; ABS. ITA; BIBL. 6 P.Article

FUNCTIONS OF T CELLS AND RECRUITMENT OF CELLULAR RESPONSE AFTER IN VITRO MITOGENIC STIMULATION OF LYMPHOCYTES IN CHRONIC LYMPHOCYTIC LEUKAEMIANERI A; PACIUCCI PA; BRUGIATELLI M et al.1979; RIC. CLIN. LAB.; ITA; DA. 1979; VOL. 9; NO 1; PP. 67-77; BIBL. 21 REF.Article

T-COLONIES IN AGAR CULTURE: CLONAL PROLIFERATION OF T-PROGENITORS OR PHA-TRANSFORMATION OF MATURE T-LYMPHOCYTESNERI A; BAGNARA GP; BIAGINI G et al.1980; BOLL. IST. SIEROTER. MILAN.; ISSN 0021-2547; ITA; DA. 1980; VOL. 59; NO 3; PP. 211-219; ABS. ITA; BIBL. 20 REF.Article

IN VITRO PROLIFERATIVE RESPONSE OF CHRONIC LYMPHOCYTIC LEUKEMIA.NERI A; ALBERTO PACIUCCI P; NOBILE F et al.1977; RIC. CLIN. LAB.; ITAL.; DA. 1977; VOL. 7; NO 2; PP. 124-135; BIBL. 1 P. 1/2Article

MULTIPLE MYELOMA IN HUSBAND AND WIFEBRUGIATELLI M; COMIS M; IACOPINO P et al.1980; ACTA HAEMATOL.; ISSN 0001-5792; CHE; DA. 1980; VOL. 64; NO 4; PP. 227-229; BIBL. 8 REF.Article

Factors affecting the uptake of prenatal diagnosis for sickle cell diseasePETROU, M; BRUGIATELLI, M; WARD, R. H. T et al.Journal of medical genetics. 1992, Vol 29, Num 11, pp 820-823, issn 0022-2593Article

Comparison of younger versus older B-cell chronic lymphocytic leukemia patients for clinical presentation and prognosis. A retrospective study of 53 casesMOLICA, S; BRUGIATELLI, M; CALLEA, V et al.European journal of haematology. 1994, Vol 52, Num 4, pp 216-221, issn 0902-4441Article

In vitro improvement of chlorambucil-induced cytotoxicity by deflazacort and 6-methylprednisolone in B-cell chronic lymphocytic leukaemiaMORABITO, F; CALLEA, I; IRRERA, G et al.European journal of haematology. 1997, Vol 58, Num 5, pp 301-306, issn 0902-4441Article

Germ-line configuration of the T-cell receptor beta-chain gene in B-cell chronic lymphoproliferative disorders which co-express T-cell antigensMORABITO, F; TASSINARI, A; CALLEA, V et al.European journal of haematology. 1987, Vol 39, Num 5, pp 412-417, issn 0902-4441Article

Retrospective analysis of mantle cell lymphoma : Experience of the Gruppo Italiano per lo Studio dei Linfomi (GISL)CALLEA, V; CLO, V; MORABITO, F et al.Haematologica - Journal of hematology. 1998, Vol 83, Num 11, pp 993-997Article

BCL-2 protein expression and p53 gene mutation in chronic lymphocytic leukemia : Correlation with in vitro sensitivity to chlorambucil and purine analogsMORABITO, F; FILANGERI, M; CALLEA, I et al.Haematologica (Roma). 1997, Vol 82, Num 1, pp 16-20, issn 0390-6078Conference Paper

In vitro sensitivity of chronic lymphocytic leukemia B-cells to fludarabine, 2-chlorodeoxyadenosine and chlorambucil : Correlation with clinico-hematological and immunophenotypic featuresMORABITO, F; STELITANO, C; CALLEA, I et al.Haematologica (Roma). 1996, Vol 81, Num 3, pp 224-231, issn 0390-6078Article

Modulation of purine analogs- and chlorambucil-induced cytotoxicity by alpha-interferon and interleukin-2 in chronic lymphocytic leukemiaMORABITO, F; CALLEA, I; RODINO, A et al.Leukemia. 1995, Vol 9, Num 9, pp 1450-1455, issn 0887-6924Article

α2-interferon in B-cell chronic lymphocytic leukemia : clinical response, serum cytokine levels, and immunophenotype modulationMORABITO, F; CALLEA, V; OLIVA, B et al.Leukemia. 1993, Vol 7, Num 3, pp 366-371, issn 0887-6924Article

Alpha thalassaemia hydrops fetalis in the UK : the importance of screening pregnant women of Chinese, other South East Asian and Mediterranean extraction for alpha thalassaemia traitPETROU, M; BRUGIATELLI, M; OLD, J et al.British journal of obstetrics and gynaecology (Print). 1992, Vol 99, Num 12, pp 985-989, issn 0306-5456Article

Immunologic and molecular evaluation of residual disease in B-cell chronic lymphocytic leukemia patients in clinical remission phaseBRUGIATELLI, M; CALLEA, V; MORABITO, F et al.Cancer. 1989, Vol 63, Num 10, pp 1979-1984, issn 0008-543XArticle

Clinical significance of sIL2R, sCD23, sICAM-1, IL6 and sCD14 serum levels in B-cell chronic lymphocytic leukemiaCALLEA, V; MORABITO, F; LUISE, F et al.Haematologica (Roma). 1996, Vol 81, Num 4, pp 310-315, issn 0390-6078Article

The in vitro cytotoxic effect of mitoxantrone in combination with fludarabine or pentostatin in B-cell chronic lymphocytic leukemiaMORABITO, F; CALLEA, I; CONSOLE, G et al.Haematologica (Roma). 1997, Vol 82, Num 5, pp 560-565, issn 0390-6078Article

Fludarabine treatment in b-cell chronic lymphocytic leukemia : response, toxicity and survival analysis in 47 casesSTELITANO, C; MORABITO, F; GRAZIA KROPP, M et al.Haematologica - Journal of hematology. 1999, Vol 84, Num 4, pp 317-323Article

In vitro drug-induced cytotoxicity predicts clinical response to fludarabine in B-cell chronic lymphocytic leukaemiaMORABITO, F; STELITANO, C; CALLEA, I et al.British journal of haematology. 1998, Vol 102, Num 2, pp 528-531, issn 0007-1048Article

2-Chlorodeoxyadenosine treatment in non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukemia resistant to conventional chemotherapy : results of a multicentric experienceBRUGIATELLI, M; HOLOWIECKA, B; LUTZ, D et al.Annals of hematology (Print). 1996, Vol 73, Num 2, pp 79-84, issn 0939-5555Article

Long-term clinical outcome of B-cell chronic lymphocytic leukaemia patients in clinical remission phase evaluated at phenotypic levelBRUGIATELLI, M; CLAISSE, J. F; LENORMAND, B et al.British journal of haematology. 1997, Vol 97, Num 1, pp 113-118, issn 0007-1048Article

Surface CD14 positivity in B-cell chronic lymphocytic leukaemia is related to clinical outcomeCALLEA, V; MORABITO, F; MOLICA, S et al.British journal of haematology. 1999, Vol 107, Num 2, pp 347-352, issn 0007-1048Article

Efficacy of two different ProMACE-CytaBOM derived regimens in advanced aggressive non-Hodgkin's lymphoma. Final report of a multicenter trial conducted by GISLFEDERICO, M; CLO, V; BALDINI, L et al.Haematologica - Journal of hematology. 1998, Vol 83, Num 9, pp 800-811Article

High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced b-cell Chronic Lymphocytic Leukemia : Results of an international multicenter randomized trialJAKSIC, B; BRUGIATELLI, M; KRC, I et al.Cancer. 1997, Vol 79, Num 11, pp 2107-2114, issn 0008-543XArticle